Home / FlashMed

FlashMed

Titolo Reducing the risk of infection in end-stage kidney failure patients treated by dialysis
Autore Sophie Collier1 and Andrew Davenport2 - 1Department of Medical Microbiology, Royal Free Hospital, London, UK and 2UCL Centre for Nephrology, Royal Free Hospital, University College London Medical School, London, UK
Referenza Nephrol Dial Transplant (2014) doi: 10.1093/ndt/gfu321
Contenuto

After cardiovascular causes, infectious diseases are the next most common cause of death for dialysis patients. The Japanese Society for Dialysis Therapy reported an increased standardized mortality of 7.5-fold [95% confidence limits (CI) 7.3–7.6] for infectious diseases between 2008 and 2009 compared with the general Japanese population. The increased mortality rates for dialysis patients were greatest for sepsis, followed in descending order by peritonitis, influenza, tuberculosis and pneumonia [1]. Patients with chronic kidney disease are more susceptible to some infections, as the azotaemic state alters innate immunity, with reports of reduced monocyte Toll-like receptor 4 expression [2], reduced B-lymphocyte cell populations [3] and impaired polymorphonuclear chemotaxis and phagocytosis [4]. It has also been proposed that changes in the gastrointestinal microbiota, and increased intestinal permeability to endotoxin, lead to a persistent activation of the innate immune system, resulting in the induction of immuneregulatory mediators which then suppress both innate and adaptive immunity [5]. Additionally, immune responses may also be impaired by poor nutritional status, malnutrition and vitamin D deficiency [6].

Data 28.10.2014
 
Maggiori informazioni   
Lista completa